Evidence map›Paper›PMID 32348330›Full record

ArticlePloS one2020

Pneumococcal colonization prevalence and density among Thai children with severe pneumonia and community controls.

Barameht Piralam, Christine Prosperi, Somsak Thamthitiwat, Charatdao Bunthi, Pongpun Sawatwong, Ornuma Sangwichian, Melissa M Higdon, Nora L Watson, Maria Deloria Knoll, Wantana Paveenkittiporn and 7 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Observational
  10. Article
  11. AsymptomaticeLife · 2021
    Observational
  12. Serotypes and Vaccine Coverage ofPathogens (Basel, Switzerland) · 2020
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Barameht PiralamDepartment of Epidemiology and Biostatistics, Khon Kaen University, Khon Kaen, Thailand.
Christine ProsperiDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Somsak ThamthitiwatDivision of Global Health Protection, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Charatdao BunthiDivision of Global Health Protection, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Pongpun SawatwongDivision of Global Health Protection, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Ornuma SangwichianDivision of Global Health Protection, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Melissa M HigdonDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID 0000-0002-1932-9442
Nora L WatsonThe Emmes Company, Rockville, Maryland, United States of America.
Maria Deloria KnollDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Wantana PaveenkittipornMinistry of Public Health, National Institute of Health, Nonthaburi, Thailand.
Chuwattana CharaNakhon Phanom Provincial Hospital, Nakhon Phanom, Thailand.
Cameron P HurstDepartment of Epidemiology and Biostatistics, Khon Kaen University, Khon Kaen, Thailand.
Pasakorn AkarasewiDepartment of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
Julia RhodesDivision of Global Health Protection, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Susan A MaloneyDivision of Global Health Protection, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Katherine L O'BrienDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Henry C BaggettDivision of Global Health Protection, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Ministry of Public Health · THJohns Hopkins University · USKhon Kaen University · THEmmes (United States) · USNakhon Phanom University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPneumococcal colonization prevalence and colonization density, which has been associated with invasive disease, can offer insight into local pneumococcal ecology and help inform vaccine policy discussions.

methodsThe Pneumonia Etiology Research for Child Health Project (PERCH), a multi-country case-control study, evaluated the etiology of hospitalized cases of severe and very severe pneumonia among children aged 1-59 months. The PERCH Thailand site enrolled children during January 2012-February 2014. We determined pneumococcal colonization prevalence and density, and serotype distribution of colonizing isolates.

resultsWe enrolled 224 severe/very severe pneumonia cases and 659 community controls in Thailand. Compared to controls, cases had lower colonization prevalence (54.5% vs. 62.5%, p = 0.12) and lower median colonization density (42.1 vs. 210.2 x 103 copies/mL, p <0.0001); 42% of cases had documented antibiotic pretreatment vs. 0.8% of controls. In no sub-group of assessed cases did pneumococcal colonization density exceed the median for controls, including cases with no prior antibiotics (63.9x103 copies/mL), with consolidation on chest x-ray (76.5x103 copies/mL) or with pneumococcus detected in whole blood by PCR (9.3x103 copies/mL). Serotype distribution was similar among cases and controls, and a high percentage of colonizing isolates from cases and controls were serotypes included in PCV10 (70.0% and 61.8%, respectively) and PCV13 (76.7% and 67.9%, respectively).

conclusionsPneumococcal colonization is common among children aged <5 years in Thailand. However, colonization density was not higher among children with severe pneumonia compared to controls. These results can inform discussions about PCV introduction and provide baseline data to monitor PCV impact after introduction in Thailand.

Indexed as

Anti-Bacterial AgentsBacterial LoadCase-Control StudiesChild, PreschoolHumansInfantMaleNasopharynxPneumococcal VaccinesPneumonia, PneumococcalPolymerase Chain ReactionPrevalenceSerogroupStreptococcus pneumoniaeThailand10-valent pneumococcal conjugate vaccine13-valent pneumococcal vaccineAnti-Bacterial AgentsPneumococcal Vaccines

Identifiers

PMID32348330
PMCPMC7190126
OpenAlexW3017894200

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.